Сравнение

Buserelin vs. Enfuvirtid

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

57982-77-1

159519-65-0

Молекулярная масса

1239.42 g/mol

4491.88 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Enfuvirtid

Enfuvirtide binds the first heptad-repeat region (HR1) of the gp41 subunit of the HIV envelope protein. This prevents the conformational change required for fusion of the viral and cell membranes — the virus cannot enter the cell.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Buserelin	Enfuvirtid
Германия	Рецептурный	Рецептурный
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Buserelin and Enfuvirtid?: Buserelin is classified as "Исследования (прочее)", while Enfuvirtid is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Enfuvirtid?: The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Enfuvirtid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Enfuvirtid in Germany and the United States?: Германия: Buserelin — Рецептурный, Enfuvirtid — Рецептурный. США: Buserelin — Не одобрено, Enfuvirtid — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Enfuvirtid

Германия

Рецептурный

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Buserelin and Enfuvirtid?

Buserelin is classified as "Исследования (прочее)", while Enfuvirtid is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Enfuvirtid?

The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Enfuvirtid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Enfuvirtid in Germany and the United States?

Германия: Buserelin — Рецептурный, Enfuvirtid — Рецептурный. США: Buserelin — Не одобрено, Enfuvirtid — Рецептурный. These are factual summaries with source and review date on the individual pages.